ArticlePsychoneuroendocrinology2024

Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.

Jordan C Barone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.